Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released Mar 7, 2024, before the open
10-K filed Mar 7, 2024, 67 days after period end · 0001171843-24-001239
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Revenue | $28.15M | $28.43M | $33.06M | $30.98M |
| Net Income | -$1.82M |
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
| -$1.67M |
| $961.00K |
| -$615.00K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
